Ruxolitinib could be considered as an option in the treatment of LONIPCs in children when other treatments are ineffective. Spirometry is a valuable tool for both diagnosis and follow-up of LONIPCs in children.
Effective treatment of late-onset noninfectious pulmonary complication with ruxolitinib in an 8-year-old boy
Di Cicco Maria
Primo
;Di Gangi Alessandro;Masini Beatrice;Peroni Diego;
2021-01-01
Abstract
Ruxolitinib could be considered as an option in the treatment of LONIPCs in children when other treatments are ineffective. Spirometry is a valuable tool for both diagnosis and follow-up of LONIPCs in children.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2021-Dicicco-ruxolitinib.pdf
accesso aperto
Tipologia:
Versione finale editoriale
Licenza:
Creative commons
Dimensione
366.52 kB
Formato
Adobe PDF
|
366.52 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
